2023 Interpreting Data from Dose-Finding Studies in Early Phase Oncology Trials to Determine the Optimal Dose View PDF
2023 Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials View PDF
Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets View PDF
Changes in ctDNA levels as an early indicator of outcomes in advanced NSCLC treated with TKI: Initial findings from a retrospective aggregate analysis of 8 clinical trials View PDF
2023 Impact of COVID-19 pandemic mitigation strategies on industry and NCI cancer treatment trials. Read more
2022 Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials Read more
